PHARMACOLOGICAL INHIBITION OF TRAF2- AND NCK-INTERACTING KINASE (TNIK) AS A TREATMENT FOR ALS

$586,740FY2025Defense Health AgencyDOD

Als Therapy Development Fnd

Investigators